Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
NEW ORLEANS — For contrast-enhanced imaging in multiple sclerosis (MS), all gadolinium-based agents accumulate in body tissue but to greatly varying degrees. While the long-term effect of gadolinium ...
Please provide your email address to receive an email when new articles are posted on . The FDA is now requiring that gadolinium-based contrast agents carry new label warnings about the risk for ...
Reveal's New Manganese-Based MRI Contrast Agent Advances Safer Patient Care · globenewswire.com CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the ...
After adjusting for gender, age, education level, baseline neurocognitive performance, and others, the authors reported gadolinium exposure was not a significant predictor of cognitive decline, ...
GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial for manganese-based MRI contrast agent under FDA Fast ...
New research suggests gadolinium retention may be more widespread and may be present in many more, or possibly all, patients exposed to gadolinium-based contrast agents, according to new research.
Gadolinium-enhanced MRI is associated with an increased risk of stillbirth or neonatal death, as well as rheumatologic, inflammatory, or infiltrative skin conditions. MRI use in the first trimester of ...
Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function. The Food and Drug Administration (FDA) announced a new class warning and safety ...
SAN FRANCISCO-- Action star Chuck Norris took on medical device manufacturers in a lawsuit filed in California on Wednesday alleging a chemical used in MRI imaging scans poisoned his wife. Gadolinium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results